{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:58:16Z","timestamp":1793383096753,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2017,4,30]],"date-time":"2017-04-30T00:00:00Z","timestamp":1493510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Abbott Vascular Int.","id":[{"id":"https:\/\/ror.org\/05d67dc31","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Amgen Cardiovascular"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Bristol Myers Squibb and Pfizer Alliance"},{"name":"The Alliance Daiichi Sankyo Europe GmbH"},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003358","name":"Gedeon Richter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003358","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Menarini Int. Op."},{"name":"MSD-Merck & Co."},{"name":"Novartis Pharma AG"},{"DOI":"10.13039\/100017647","name":"ResMed","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"SERVIER","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To identify differences in clinical epidemiology, in-hospital management and 1-year outcomes among patients hospitalized for acute heart failure (AHF) and enrolled in the European Society of Cardiology Heart Failure Long-Term (ESC-HF-LT) Registry, stratified by clinical profile at admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The ESC-HF-LT Registry is a prospective, observational study collecting hospitalization and 1-year follow-up data from 6629 AHF patients. Among AHF patients enrolled in the registry, 13.2% presented with pulmonary oedema (PO), 2.9% with cardiogenic shock (CS), 61.1% with decompensated heart failure (DHF), 4.8% with hypertensive heart failure (HT-HF), 3.5% with right heart failure (RHF) and 14.4% with AHF and associated acute coronary syndromes (ACS-HF). The 1-year mortality rate was 28.1% in PO, 54.0% in CS, 27.2% in DHF, 12.8% in HT-HF, 34.0% in RHF and 20.6% in ACS-HF patients. When patients were classified by systolic blood pressure (SBP) at initial presentation, 1-year mortality was 34.8% in patients with SBP &amp;lt;85 mmHg, 29.0% in those with SBP 85\u2013110 mmHg, 21.2% in patients with SBP 110\u2013140 mmHg and 17.4% in those with SBP &amp;gt;140 mmHg. These differences tended to diminish in the months post-discharge, and 1-year mortality for the patients who survived at least 6 months post-discharge did not vary significantly by either clinical profile or SBP classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Rates of adverse outcomes in AHF remain high, and substantial differences have been found when patients were stratified by clinical profile or SBP. However, patients who survived at least 6 months post-discharge represent a more homogeneous group and their 1-year outcome is less influenced by clinical profile or SBP at admission.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.890","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T10:00:41Z","timestamp":1493719241000},"page":"1242-1254","source":"Crossref","is-referenced-by-count":560,"title":["Clinical Phenotypes and Outcome of Patients Hospitalized for Acute Heart Failure: The ESC Heart Failure Long-Term Registry"],"prefix":"10.1093","volume":"19","author":[{"given":"Ovidiu","family":"Chioncel","sequence":"first","affiliation":[{"name":"University of Medicine Carol Davila, Bucuresti; Institutul de Urgente Boli Cardiovasculare C.C. Iliescu , Bucuresti ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[{"name":"University Paris Diderot, Sorbonne Paris Cit\u00e9, Paris, France; 4APHP, Department of Anaesthesia and Critical Care, H\u00f4pitaux Universitaires Saint Louis-Lariboisi\u00e8re , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli-Pekka","family":"Harjola","sequence":"additional","affiliation":[{"name":"Emergency Medicine, Helsinki University, Department of Emergency Medicine and Services, Helsinki University Hospital , Helsinki ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Coats","sequence":"additional","affiliation":[{"name":"Monash University, Australia and University of Warwick , Coventry ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo Francesco","family":"Piepoli","sequence":"additional","affiliation":[{"name":"Heart Failure Unit, Cardiac Department, Guglielmo da Saliceto Hospital , AUSL Piacenza ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Crespo-Leiro","sequence":"additional","affiliation":[{"name":"Unidad de Insuficiencia Cardiaca Avanzada y Trasplante Cardiaco, Complejo Hospitalario Universitario A Coruna (CHUAC), CIBERCV , La Coruna ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Laroche","sequence":"additional","affiliation":[{"name":"EURObservational Research Programme, European Society of Cardiology , Sophia Antipolis ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petar M.","family":"Seferovic","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Belgrade University School of Medicine and Heart Failure Centre, Belgrade University Medical Centre , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[{"name":"Innovative Clinical Trials, Department of Cardiology and Pneumology, University Medical Center G\u00f6ttingen (UMG) , G\u00f6ttingen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Department of Cardiology and LTTA Centre, University Hospital of Ferrara and Maria Cecilia Hospital, GVM Care and Research, ES Health Science Foundation , Cotignola ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Ruschitzka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart Failure Clinic and Transplantation, University Heart Centre Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Lopez-Fernandez","sequence":"additional","affiliation":[{"name":"Cardiology, Hospital Universitario Virgen de las Nieves , Granada ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Miani","sequence":"additional","affiliation":[{"name":"Cardiology, University Hospital S. Maria della Misericordia , Udine ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, School of Medicine, University Hospital Attikon , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[{"name":"ANMCO Research Center , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,4,30]]},"reference":[{"key":"2026011721195924900_ejhf890-bib-0001","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0002","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"2026011721195924900_ejhf890-bib-0003","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0004","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure\u2014lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026011721195924900_ejhf890-bib-0005","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ejheart.2006.01.001","article-title":"Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study","volume":"8","author":"Zannad","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0006","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00134-010-2113-0","article-title":"Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)","volume":"37","author":"Follath","year":"2011","journal-title":"Intensive Care Med"},{"key":"2026011721195924900_ejhf890-bib-0007","doi-asserted-by":"crossref","first-page":"R291","DOI":"10.1186\/cc10584","article-title":"Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry","volume":"15","author":"Spinar","year":"2011","journal-title":"Crit Care"},{"key":"2026011721195924900_ejhf890-bib-0008","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ahj.2011.03.033","article-title":"The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry","volume":"162","author":"Chioncel","year":"2011","journal-title":"Am Heart J"},{"key":"2026011721195924900_ejhf890-bib-0009","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/eurjhf\/hfs117","article-title":"Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome","volume":"14","author":"Oliva","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/eurjhf\/hfs189","article-title":"Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study","volume":"15","author":"Logeart","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0011","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0195-668X(02)00823-0","article-title":"The EuroHeart failure survey programme\u2014a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis","volume":"24","author":"Cleland","year":"2003","journal-title":"Eur Heart J"},{"key":"2026011721195924900_ejhf890-bib-0012","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","article-title":"EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population","volume":"27","author":"Nieminen","year":"2006","journal-title":"Eur Heart J"},{"key":"2026011721195924900_ejhf890-bib-0013","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/eurheartj\/ehl407","article-title":"Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure","volume":"27","author":"Siiril\u00e4-Waris","year":"2006","journal-title":"Eur Heart J"},{"key":"2026011721195924900_ejhf890-bib-0014","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","article-title":"Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0015","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ejhf.566","article-title":"European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions","volume":"18","author":"Crespo-Leiro","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0016","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/CIR.0000000000000156","article-title":"2014 ACC\/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)","volume":"132","author":"Hicks","year":"2015","journal-title":"Circulation"},{"key":"2026011721195924900_ejhf890-bib-0017","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2459\/JCM.0000000000000192","article-title":"Epidemiology, pathophysiology, and in-hospital management of pulmonary edema: data from the Romanian Acute Heart Failure Syndromes registry","volume":"17","author":"Chioncel","year":"2016","journal-title":"J Cardiovasc Med"},{"key":"2026011721195924900_ejhf890-bib-0018","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/eurjhf\/hfq138","article-title":"Acute pulmonary oedema: clinical characteristics, prognostic factors, and in-hospital management","volume":"12","author":"Parissis","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0019","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock","volume":"17","author":"Harjola","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0020","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/eurheartj\/ehp458","article-title":"The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study","volume":"31","author":"Mebazaa","year":"2010","journal-title":"Eur Heart J"},{"key":"2026011721195924900_ejhf890-bib-0021","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ejhf.478","article-title":"Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology","volume":"18","author":"Harjola","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0022","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/eurjhf\/hfq154","article-title":"EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot)","volume":"12","author":"Maggioni","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0023","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/eurjhf\/hfq045","article-title":"Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine","volume":"12","author":"Gheorghiade","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0024","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10741-015-9485-8","article-title":"Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations","volume":"20","author":"Vaduganathan","year":"2015","journal-title":"Heart Fail Rev"},{"key":"2026011721195924900_ejhf890-bib-0025","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/eurjhf\/hft050","article-title":"EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0026","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/CIRCHEARTFAILURE.112.000161","article-title":"Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) Outcome Registry","volume":"6","author":"Tavazzi","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0027","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/eurjhf\/hfq002","article-title":"Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure","volume":"12","author":"Harjola","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026011721195924900_ejhf890-bib-0028","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejim.2012.11.005","article-title":"Long-term survival following acute heart failure: The Acute Heart Failure Database-Main registry (AHEAD Main)","volume":"24","author":"Parenica","year":"2013","journal-title":"Eur J Intern Med"},{"key":"2026011721195924900_ejhf890-bib-0029","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2459\/JCM.0000000000000329","article-title":"Natriuretic peptide-guided management in heart failure","volume":"17","author":"Chioncel","year":"2016","journal-title":"J Cardiovasc Med"},{"issue":"Suppl G","key":"2026011721195924900_ejhf890-bib-0030","doi-asserted-by":"crossref","first-page":"G19","DOI":"10.1093\/eurheartj\/suw045","article-title":"The bumpy road to drug development for acute heart failure","volume":"18","author":"Hamo","year":"2016","journal-title":"Eur Heart J"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.890","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/19\/10\/1242\/66327789\/eurjhf_19_10_1242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/19\/10\/1242\/66327789\/eurjhf_19_10_1242.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:22:11Z","timestamp":1768702931000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/19\/10\/1242\/8418512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,30]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,4,30]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.890","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10]]},"published":{"date-parts":[[2017,4,30]]}}}